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Goniothalamus Species: A Source of Drugs for the Treatment
of Cancers and Bacterial Infections?
Christophe Wiart
School of Pharmacy, The University of Nottingham (Malaysia Campus), Jalan Broga, 43500 Semenyih,
Selangor, Malaysia
Irrespective of the presence of cytotoxic acetogenins and styryl-lactones in the genus
Goniothalamus, only 22 species in the genus Goniothalamus, out of 160 species (13.7%) have
so far been investigated. In an effort to promote further research on the genus Goniothalamus
which could represent a source of drugs for the treatment of cancers and bacterial infections,
this work offers a broad analysis of current knowledge on Goniothalamus species. Therefore,
it includes (i) taxonomy (ii) botanical description (iii) traditional medicinal uses and
(iv) phytochemical and pharmacological studies. We discuss the molecular mechanisms of
actions of acetogenins and styryl-lactones, with some emphasis on the possible involvement of
protein kinase, Bax and TRAIL receptors in the cytotoxic effects of styryl-lactones. We also
report (v) the growth inhibition of several nosocomial bacteria by Goniothalamus. scortechinii.
The crude methanol extract of G. scortechinii showed a good and broad spectrum of
antibacterial activity against both Gram-negative and Gram-positive bacteria.
Keywords: acetogenins–antibacterial–antifungal–apoptosis–cytotoxic–foodborn bacteria–
Goniothalamus–Goniothalamus scortechinii–nosocomial–styryl-lactones.
Introduction
The genus Goniothalamus Hk. f. et Thoms. (Family
Annonaceae A.L. de Jussieu 1789 nom. conserv., the
Custard-Apple Family) consists of 160 species of archaic
shrubs and treelets which grow in the shady primary
rainforest of tropical Asia. These plants can be quickly
spotted in field collection by their aromatic bark
and fusiform leathery flowers (1,2). A number of
Goniothalamus species have been used for timber, as
fiber sources (2), for ornamental and medicinal purposes,
especially in relation with post-partum and abortion
(3,4). The genus Goniothalamus belongs to a primitive
taxon of flowering plants: the Annonaceae (Family
Annonaceae A.L. de Jussieu 1789 nom. conserv.,
the Custard-Apple Family) (5). The Annonaceae form
a large, generally recognizable family of about 122 genera
and 2000 plant species which are widespread chiefly in
tropics and subtropics (6–8). In regards to the pharma-
cological potentials of Goniothalamus species, there is a
massive body of evidence to suggest that this taxon has
the ability to elaborate series of acetogenins and styryl-
lactones which are cytotoxic against a broad array of
cancer cells including breast, colon, kidney and pancrea-
tic carcinoma cells. Interestingly, both acetogenins and
styryl-lactones are completely different in terms of
chemical structure but their cellular activities are invol-
ving the same organelles in mammals: the mitochondria.
An exciting fact about the mode of action of styryl-
lactones, which is still an enigma, is their possible action
via protein kinase and TRAIL receptors. In an effort to
promote further research on the genus Goniothalamus
which could be a promising source for chemotherapeutic
agents, this work offers a broad analysis of current
knowledge on Goniothalamus species. We also highlight
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properly cited.the antibacterial activity of Goniothalamus scortechinii.
This is the first antibacterial study report on
Goniothalamus species.
Botanical Description
The botanical characteristics of Goniothalamus species
are homogenous and simple. When searching for
Goniothalamus species in the rainforest, one is advised
to look for few-leaved slender treelets or shrubs with
smooth, thin and fibrous and strongly aromatic bark and
upright blackish cylindrical trunk. The leaves are few,
simple, alternate and exstipulate. The blade is glossy,
oblong—lanceolate to obovate and thick. The secondary
nerves are oblique, conspicuous, straight and parallel
with scalariform reticulations (9). The flowers are axillary
and characteristically woody, often dark green and
fusiform (Fig. 1). The calyx consists of three sepals
which are valvate, membranous, veined, free or connate.
The corolla consists of two series of three petals which
are veined and coriaceous, the inner smaller and fused in
a vault above the androecium. The outer petals are
marked with a prominent midrib. The androecium
comprises several stamens which are linear and oblong.
The gynaecium consists of several free carpels grooved at
the anterior side. The fruits are stalked or sessile one to
two seeded ripe carpels (6). The geographical pattern
of distribution of this genus suggests the genus
Goniothalamus to have been among the flowering plants
to have colonized hearth during the post-Permian early
Cretaceous time.
Traditional Medicinal Uses
Out of 160 species, five Goniothalamus species are
medicinal. These have been used in traditional medicinal
Asian system, and since a long period of time most of
these in connection with abortion, childbirth and fever
(10). The leaves of G. macrophyllus Hook.f & Thoms. are
used to allay fever and a decoction of the roots is given
as a post-partum remedy and to cause abortion (3). In
Malaysia, a decoction of leaves is used externally to allay
fever (3). The roots of G. giganteus Hook.f & Thoms. are
used to abort and treat colds and the heated leaves are
applied onto swellings (10). A decoction of G. scortechinii
is given as a post-partum protective remedy (3). The
roots of G. tapis Miq. are used as abortifacient during
early months of pregnancy (3). In Java, Indonesia, an
infusion of the roots is used to treat typhoid fever (11).
In Taiwan, the seeds of G. amuyon Merr. are used to
treat scabies (12). In the Philippines, the seeds are used
to treat rheumatism and tympanites, and the fruit is
stomachic (4). None of the traditional uses previously
mentioned has been substantiated yet via strict
pharmacological experimentation. However, these species
have been studied for their chemical constituents.
Phytochemical and Pharmacological Studies
General Concept
Twenty-two species (13.7%) in the genus Goniothalamus,
out of 160 species, have so far been phytochemically
investigated namely: G. amuyon, G. andersonii
J.Sincl., G. arvensis Scheff, G. borneensis Mat-Salleh,
G. cardiopetalus, G. cheliensis. Hu, G. donnaiensis Finet &
Gagnep., G. gardneri Hook. f. & Thoms., G. giganteus
Hook. f. & Thoms., G. griffithii Hook.f. & Thoms.,
G. howii Merr., G. leiocarpus (W.T.) Wang P.T. Li,
G. malayanus Hook.f. & Thoms., G. marcanii Craib, G.
montanus J. Sincl., G. scortechinii, G. sesquipedalis Hook.
f. & Thoms., G. tapis Miq., G. thwaitesii Hook. f. &
Thoms., G. umbrosus J. Sincl., G. uvaroides King and G.
velutinus Airy Shaw. These phytochemical studies have
resulted so far in the isolation of two very distinct classes
of lipophilic secondary metabolites: acetogenins and
styryl-lactones, both of them possessing complex stereo-
chemistry and existing in different stereoisomeric
forms (13). Testing of these chemicals for cytotoxicity
showed that both acetogenins and styryl-lactones are
toxic for several human tumors cell lines. Note that
both acetogenins and styryl-lactones are cytotoxic for
mammalian cells as the result of distinct biochemical
pathways which however take both their molecular
origin near or in the mitochondrial membrane and or
mitochondrial respiratory system (14). To date some
evidence clearly demonstrate that acetogenins have
beneficial effects against the growth of tumors, including
ovarian tumors (15), gastric tumors (16) and multidrug-
resistant cancerous xenografts (17) via the activation of
caspases enzymatic cascades (18). Most phytochemical
reports found so far on Goniothalamus species deal
with the chemical constituents of a medicinal species:
G. giganteus which abounds with cytotoxic acetogenins
(Table 1) as mentioned further.
Acetogenins: Unusual Polyketides
Acetogenins are unusual series of polyketides which have
so far only been characterized from members of the
family Annonaceae including in the genus Goniothalamus
particularly G. giganteus,G .donnaiensis and G. gardneri
(9,10). In the genus Goniothalamus, acetogenins were first
characterized as the active principles responsible for
shrimp lethality from the bark of G. giganteus collected
from Thailand. Extract of the bark showed toxicity in the
brine shrimp test and showed murine cytotoxicity in the
3PS (P388) leukemia bioassay. The cytotoxicity of this
extract compelled a series of phytochemical studies which
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Figure 1. Acetogenins from Goniothalamus species.
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1Table 1. Antitumor activity of Goniothalamus species
Species Chemical component Cells Dose Cell cycle/apoptosis
G. giganteus 4-Deoxyanomontacin (27) A-549
a 6.45 10
 7mg/ml
MCF-7
b 5.77 10
 7mg/ml
HT-29
c 1.41 10
 1mg/ml
A-498
d 1.50 10
 1mg/ml
PC-3
e 1.73 10
 1mg/ml
PACA-2
f 1. 10
 5mg/ml
(2,4-cis and trans)-
annomontacinone (27)
HT-29 2.55 10
 1mg/ml
PACA-2 6.78 10
 1mg/ml
cis-Gigantrionenin (32) A-549 5.99 10
 2mg/ml
MCF-7 2.68 10
 1mg/ml
HT-29 6.94 10
 6mg/ml
A-498 1.39 10
 2mg/ml
PC-3 1.11 10
 1mg/ml
PACA-2 1.15 10
 1mg/ml
4-Acetylgigantetrocin (25) A-549 510
 2mg/ml
MCF-7 8.5 10
 1mg/ml
HT-29 510
 2mg/ml
A-498 1.55 10
 1mg/ml
PACA-2 510
 2mg/ml
Annonacin (19) PA1
g 0.452mg/ml G1
SKOV3
h 0.411mg/ml
HeLa
i 0.219mg/ml
HeLa S3
j 0.426mg/ml
MCF-7 0.433mg/ml
T-24
k 0.324mg/ml
BCC-1
l 0.427mg/ml
Gigantransenin A (26) A-549 0.16mg/ml
Gigantransenin B (26) A-549 0.21mg/ml
MCF-7 2.1 10
 1mg/ml
Gigantrasenin C (26) A-549 0.18mg/ml
Goniotetrocin (29) A-549 3.9 10
 1mg/ml
PC-3 2.1 10
 1mg/ml
PACA-2 2.6 10
 2mg/ml
(2,4-cis and trans)
Gonioneninone (29) PACA-2 4.5 10
 2mg/ml
Goniothalamicin (24) A-549 2.8010
 1mg/ml
Gonionenine (24) PACA-2 4.5 10
 1mg/ml
Pyranicin (30) A-549 2.8 10
 1mg/ml
MCF-7 3.6 10
 1mg/ml
A-498 1.8 10
 1mg/ml
PACA-2 1.3 10
 3mg/ml
Deoxyannomontacin (27) A-549 6.45 10
 7mg/ml
MCF-7 1.41 10
 1mg/ml
A-498 1.50 10
 1mg/ml
PACA-2 1.5 10
 5mg/ml
Annomontacinone (27) HT-29 2.55 10
 1mg/ml
(continued)
302 Goniothalamus for cancer treatmentresulted in the identification of a series of cytotoxic
acetogenins including notably: (2,4-cis and trans-)-
annomontacinones (i), annonacin (ii), giganenin (iii),
gigantecin (iv), 4-deoxygigantecin, (2,4-cis and trans)-
gigantecinones, 4-acetylgigantetrocin A (v), goniotrionin
(vi), gigantransenin A (vii) and C (viii), gigantrionenin
(ix), gigantetrocin (x), goniotetrocine (xi), (2,4-cis and
trans)-gigantetrocinones, gonionenin (xii), (2,4-cis and
trans)-gonioneninones (xiii), 4-deoxygigantenin (xiii),
4-deoxyannomontacin (xiv), goniothalamicin (xv),
pyranicin (xvi), gigantriocin (xvii), goniotriocin, (2,4-cis
and trans)-isoannonacins, longicoricin, longifolicicin,
longimicin C, cis-gigantrionenin (xviii), pyragoniocin
(xix), xylomaticin, and (2,4-cis and trans)-xylomaticinones
(Fig. 1) (19–33). Gigantransenins A, and C showed
selective inhibitory effects on the human breast tumor
cell-line (MCF-7) comparable with the potency of
adriamycin (26). Both goniotetracin, and 2,4-cis- and
trans-gonioneninone are selectively and significantly
cytotoxic to the human pancreatic tumour cell line
(PACA-2) (29). Pyranicin exhibited a selective cytotoxic
against the pancreatic cell line (PACA-2) in a panel of
six human solid tumor cell lines, with pyranicin showing
10 times the potency of adriamycin (30).
Table 1. Continued
Species Chemical component Cells Dose Cell cycle/apoptosis
G. giganteus Annomontacinone (27) PACA-2 6.78 10
 1mg/ml
Pyragonicin (30) A-549 510
 2mg/ml
HT-29 3.4 10
 1mg/ml
A-498 1.55 10
 1mg/ml
PACA-2 5.8 10
 3mg/ml
Goniotrionin (30) A-549 7.7 10
 3mg/ml
MCF-7 8.5 10
 1mg/ml
MCF-7 5.3 10
 6mg/ml
A-498 2.10
 3mg/ml
PC-3 3.6 10
 1mg/ml
PACA-2 5.4 10
 3mg/ml
G. donnaiensis Goniodonin (34,35) HCT-8
m 510mg/ml
Donhexocin (34,35) HCT-8 0.82mg/ml
Donbutocin (34,35) L1210 0.81mg/ml
G. gardneri Gardnerilin A (37) Bel7402n 3.6mg/ml
Gardnerilin B (37) Bel7402
n 8.5mg/ml
G. andersonii Goniothalamin (47) HL-60
o apoptosis
Jurkat T
p apoptosis
G. griffithii Goniothalamin (82) HepG2 8.83mM G2/apoptosis
HepG2R 8mM
Altholactone (82) HepG2 0.7mM apoptosis
HepG2R 6.17mM
Goniodiol (82) HepG2 10mMG 2
HepG2R 8.33mM
G. malayanus Altholactone (74,76) HL60 apoptosis
G. borneensis Goniothalamin (49) P388 0.75mg/ml
WEHI164 1.70mg/ml
MOLT-4 51mg/ml
G. howii Howiinol (79) L1210 6.85mg/ml G1
G. cheliensis Goniolactone B (54) A2780 7.40mM
HCT-8 4.43mM
KB 7.23mM
Synthesized Goniothalamin (66) MCF-7 10.5mM
HT-29 11.2mM
ahuman lung carcinoma;
bhuman breast carcinoma;
chuman colon adenocarcinoma;
dhuman kidney carcinoma,
ehuman prostate adenocarcinoma,
fhuman pancreatic carcinoma,
g,hovarian cancer cells;
I,jcervical cancer;
kbladder cancer;
lskin cancer,
mhuman colon adenocarcinoma,
nhepatoma
cell-line,
oleukemia cells,
ppromyelocytic leukemia cells;
qEhrlich ascites tumor cells.
eCAM 2007;4(3) 303Jiang et al. isolated donhepocin (xx), goniodin (xxi),
donhexocin (xxii) and donbutocin (xxiii), from
G. donnaiensis Finet & Gagnep. collected from Guangxi
Province, China (34–36). Gardnerilins A (xxiv) and B
(xxv) from G. gardneri Hook.f. & Thoms collected from
DiaoLo mount, Hainan Province, China, gave cytotoxic
IC50 values against Bel 7402 human tumor cell lines of
3.6 and 8.5mg/ml, respectively (37,38) (Fig. 1). The mode
of action of acetogenins is discussed next.
Mode of Action of Acetogenins: Inhibition of
NADH-ubiquinone Oxidoreductase
Acetogenins have very potent and diverse biological
effects owing to the fact that they inhibit enzymatic
activity of a key enzyme in Eukaryotic cells: mitochon-
drial NADH-ubiquinone oxidoreductase (complex I).
To date the most potent existing inhibitor of this
enzyme is an acetogenin known as bullatacin (39–41).
In regards to the precise molecular mode of action of
acetogenins against the enzyme, there is an expanding
body of evidences to suggest that the most lipophilic
moieties are embedded in the mitochondrial membrane
allowing suitable position of the pharmacophore. One
might set the hypothesis that the tetrahydrofuran (THF)
or tetrahydropyran rings as well as the free alkyl
substituent fix the molecule, whereas the lactones
maintained by an alkyl spacer acts on the active site of
the enzyme as illustrated in Fig. 2 (42,43). The work
of Motoyuki et al. (13) lends strong support to that
hypothesis. They synthesized series of acetogenins and
assessed their activity against bovine heart mitochondrial
complex I and showed that the length of the alkyl spacer
and the polarity of THF surroundings were very
important structural factor and that the g-lactone and
THF ring moieties act in a cooperative manner on
complex I with the support of some specific conformation
of the alkyl spacers as illustrated in Fig. 2.
The cytotoxic activity of acetogenin has prompted
further work in an effort to discover synthetic acetogenins
(44–46). Oberlies et al. (41) studied the cytotoxicity of
acetogenins toward cancerous and normal cells and
showed that they are selectively cytotoxic against
cancerous cells and also effective for drug-resistant
cancer cells, while exhibiting only minimal toxicity to
‘normal’ non-cancerous cells. However, further work is
needed to render acetogenins more specific to cancerous
cells and very much less active against normal cells or
significantly heavy side-effects will preclude clinical trials.
A possible approach would perhaps be to use antigen-
guided or receptor-guided forms of administrations by
associating acetogenins to specific carriers, hemisynthesis
could be of value in this instance. More specific cytotoxic
principles from Goniothalamus species are styryl-lactones
reviewed in the next section.
Styryl-lactones: Phenolic Compounds
Styryl-lactones are low molecular weight phenolic
compounds, which, like acetogenins are essentially
found in members of the Annonaceae family and present
a lactonic pharmacophore (9). Examples of styryl-
lactones from Goniothalamus species are goniothalamin
(i), altholactone (ii) and cardiopetalolactone (iii) (Fig. 3).
Jewers et al. (47) first reported goniothalamin as the
active constituent of the bark of G. andersonii, G.
macrophyllus Miq. and G. malayanus collected in the
peat-swamp of Sarawak. Altholactone was characterized
from G. arvensis Scheff. collected in the National Park of
Varirata in the Central Province of Papua New Guinea
and from the G. borneensis Mat-Salleh collected in
Malaysia (48,49). Cardiopetalolactone was characterized
from the stem bark of G. cardiopetalus Hook.f. & Thoms.
collected from Palaruvi forest in Kerala in India, with
altholactone, goniopypyrone, goniothalamin, goniodiol
(iv), goniofufurone (v) and goniofupyrone (vi) (50,51).
Goniofufurone, goniopypyrone, goniothalamin, gonio-
diol, goniotriol (vii) and 8-acetylgoniotriol (viii) were
isolated from the roots of G. griffithii (52,53). An isomer
of altholactone, (þ)-isoaltholactone (ix), was isolated
from stem bark of G. malayanus, and from the leaves of
G. montanus J. Sincl. and the roots of G. tapis Miq. (54).
Goniolactones A–F were identified from the roots of
G. cheliensis (55). Digoniodiol, deoxygoniopypyrone A,
NADH NAD+ + H+
HO
OH
OH
MIN
IMS
Complex I
MM
O
O
O
O
Figure 2. Hypothetical molecular mode of action of bullatacin against
Complex I. MM: Mitochondrial Matrix, MIN: Mitochondrial Inner
Membrane; IS: Intermembrane Space.
304 Goniothalamus for cancer treatmentgoniofupyrone, goniothalamin, deoxygoniopypyrone A,
gonodiol-8-monoacetate and gonotriol (x) and were
characterized from the aerial parts of G. amuyon collected
in the southern part of Taiwan near the coastal regions
(56–59). The petroleum ether extract of the stem bark
of G. sesquipedalis collected in Bangladesh yielded
5-isogoniothalamin oxide (60). 5-Acetyl goniothalamin
(xii) was characterized from G. uvaroides King collected
in Bangladesh (61). Chen et al. (62) isolated howiinol A
from G. howii Merr. (xii). The mode of cytotoxic action
of styryl-lactone is described subsequently.
Mode of Cytotoxic Action of Styryl-lactones: Apoptosis
The evidence currently available clearly indicate that
goniothalamin and congeners are toxic for several sorts
of cancer cells cultured in vitro including HL-60 leukemia
cells, breast cancer cell line MCF-7, liver cancer cell line
HepG2, PANC-1, HeLa cell lines (63–80) (Table 1).
Current paradigms of apoptosis suggest that styryl-
lactones from Goniothalamus activate in mammalian
cells the caspases enzymatic cascades via a loss of
mitochondrial transmembrane which results in the release
of mitochondrial cytochrome c (72). To date, the very
precise premitochondrial mechanism involved in this
activation remains an enigma, and an exciting fact is
that the activation of caspases, 3, 6, 7 and 9 is a sign
of TRAIL receptors/Bax activation (65). Other examples
of goniothalameous styryl-lactones of possible chemo-
therapeutic value are altholactone, goniolactone B and
howiinol. Altholactone is apoptogenic in HL-60
O
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Figure 3. Styryl-lactones from Goniothalamus species.
eCAM 2007;4(3) 305promyelocytic leukemia cells via oxidative stress and
mitochondrial respiratory abrogation (75,76).
Goniolactone B exhibited significant cytotoxicity against
A2780, HCT-8 and KB cells with IC50 values of 7.40,
4.43 and 7.23mM, respectively (55). Howiinol A showed
significant antitumor activities toward human tumor cell
in vitro and in vivo (77–81). A remarkable advance in the
pharmacological knowledge of howiinol A has been
provided by the work of He et al. Using techniques of
cell growth curve determination, MTT test, soft agar
colony assay and experimental therapy of transplantable
tumors in mice, they showed that howiinol exerts potent
inhibitory effect on cancer cells including drug-resistant
cell line, KB/VCR 2000, whereas normal cells are less
affected. Howiinol is active in rodents infected with H22
hepatoma and Lewis lung cancer and ascetic sarcoma
180. In addition to flow cytometry technique, they
showed that the cycle of howiinol A block is used to
analyze the cell cycle of L1210 cells from G1 phase to S
phase with structural damage on DNA molecules.
Tian et al. (82) showed that Goniothalamus styryl-lactones
which are cytotoxic against both HepG2 and HepG2-R
cell lines show less toxicity on normal mice hepatocytes
as the IC50 values of them on normal mouse hepatocytes
were about 3 times of that on HepG2. They demon-
strated that cells treated with goniothalamin and
altholactone stopped to multiply at G(2)/M and were
apoptotic, whereas cells with chromosomes gathered
at the equator were easily found in gonodiol-treated
cultures.
Indicating that not all Goniothalamus styryl-lactones are
exclusively apoptogenic, Zhong et al. (83) investigated
the apoptosis-inducing effect of styryl-lactones from G.
cheliensis, on human promyelocytic leukemia HL-60 and
showed the activation of caspase-3, reduced the expres-
sion of the anti-apoptotic gene Bcl-2, and increased the
expression of the pro-apoptotic gene Box via cAMP-
dependent protein kinase mechanism. Taking into con-
sideration the available evidence, one might propose the
hypothesis that goniothalamin and congeners induce
apoptosis at the TRAIL-BAX system level via protein
kinase modulation. Protein kinase has long been
known to be involved in cell growth and proliferation.
Wang et al. showed that protein kinase is involved in
apoptosis mediated by TRAIL (tumor necrosis factor-
related apoptosis-inducing ligand) (84). An example
of styryl-lactone which inhibits kinase is flavokavain
A from kava, or Piper methysticum in the closely
related family Piperaceae (85). The Fig. 4 shows the
similitude of chemical structure between flavokavain and
goniothalamin.
A possible mechanism of action for Goniothalamus
styryl-lactones would be a cAMP-dependent protein
kinase-mediated TRAIL-induced apoptosis, by stimulat-
ing TRAIL-induced translocation of Bax from cytosol
to mitochondria, loss of mitochondrial transmembrane
potential, and subsequent release of cytochrome c from
mitochondria and activation of caspases, SMAC/Diablo,
endo G and finally chromatin deterioration (Fig. 5).
Protein kinase modulators are of immense therapeutic
usefulness. Note that flavokavains are present in the
genus Goniothalamus, as discussed next.
Other Phytochemicals
The aerial parts of G. gardneri have yielded the
known flavonoids 20-hydroxy-4,40,60-trimethoxychalcone
(flavokavain A), 20,40-dihydroxy-4,60-dimethoxydihydro-
chalcone, 4,20,40-trihydroxy-60-methoxydihydrochalcone,
5,7,40-trimethoxyflavanone (naringenin trimethyl ether)
and 7-hydroxy-5,40-dimethoxyflavanone (tsugafolin)
together with three novel compounds, the dimer
characterized as (rel)-1b,2a-di-(2,4-dihydroxy-6-
methoxybenzoyl)-3b,4a-di-(4-methoxyphenyl)-cyclobutane,
20,40-dihydroxy-4,60-dimethoxychalcone and 20-hydroxy-
4,40,60-trimethoxydihydrochalcone (86). A similar study
of the aerial parts of G. thwaitesii led only to the isolation
of the known flavonoids myricetin 40-O-methyl ether-3-
O-a-L-rhamnopyranoside (mearnsitrin) and myricetin-3-
O-methyl ether (annulatin), together with a series of
triterpenes friedelinol, friedelin and betulinic acid (86).
Isoquinoline alkaloids were characterized from G. amuyon
(87). Other miscellaneous secondary metabolites isolated
from members of this genus include goniopedaline,
a phenanthrene lactam, aristololactam A-II and
its N,O-diacetyl derivative, taliscanine, aurantiamide
acetate and b-sitosterol and its b-D-glucoside were
isolated from the leaves and twigs of G. sesquipedalis
Hook.f. & Thoms. (88). 3-Amino naphthoquinones were
characterized from the stem bark of G. marcanii (89).
Alkaloids were characterized from G. griffithii and
essential oils were distilled from G. malayanus, G.
uvarioides, G. macrophyllus and G. andersonii (90,91).
In the genus Goniothalamus, 138 species still await to be
phytochemically investigated, including G. scortechinii,
the antibacterial property of which is reported in the next
section.
H3CO OCH3 OCH3
OCH3 O
O
O
Flavokavain A Goniothalamin
Figure 4. Note the proximity of chemical structure between flavokavain
A, an inhibitor of protein kinase, and goniothalamin. What is the
precise activity of styryl lactones against protein kinases?
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G. scortechinii or in Malay akar gajah beranak (climber
of the elephant bringing forth) is a small tree found
from Penang to Selangor and Pahang used by Malays
apparently freely, either alone or with other substances
after childbirth, and taken internally to prevent bacterial
infection (3). The plant is known to exhibit potent
schizonticidal activity in vitro (92). We report the first
evaluation of the antibacterial activity of hexane,
dichloromethane and aqueous fractions of G. scortechinii.
The plant was collected from 6  North and 98  East, near
Kuala Kangsar, State of Perak, Malaysia in August 2004,
300m above sea level. The plant material was identified
on comparison with specimens available at the
Herbarium of the ‘Forest Research Institute of
Malaysia’, Kepong, Malaysia. A voucher specimen
(number W1332) has been deposited in our Herbarium
collection for future reference. Finely powdered, air-dried
leaves of G. scortechinii (800g) were extracted with
methanol (2l) using a soxhlet apparatus. Hexane
(250ml), dichloromethane (250ml), and water fractions
(250ml) were obtained by the partitioning of liquid
methanol extract (250ml) (yield: 5.52, 8.43, 64.5).
1
PK
Mitochondria
Cytoplasm
Trail
Trail receptor
Extracellular lumen
2
BAX
Endo G
SMAC/DIABLO
Cyt. c
3
4
5
6
Nucleus
DNA
Chromatin
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C
Figure 5. Putative mechanism of action of Goniothalamus styryl-lactones in apoptosis. TRAIL R: TRAIL receptor, Cyt. c: Cytochrome c;
C: caspases. 1: styryl-lactone interacts with cellular kinase, 2: kinase mediation of TRAIL induction of apoptosis, 3: TRAIL induced
translocation of Bax to mitochondria, 4, 5: release of cytochrome C and activation of caspases, SMAC/Diablo, EndoG, 6: chromatin condensation
and cellular death.
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rotary evaporator and brought to complete dryness over
water bath to yield the crude extracts. Hexane fraction
(yield: 5.52) gave a positive chemical test for steroids,
dichloromethane fraction (yield: 8.43) gave a positive
chemical test for steroids and terpenes, and aqueous
fraction (yield: 64.5) gave a positive chemical test for
tannins (93). These extracts were screened for antibacte-
rial activity using the following antibacterial assay.
The crude methanol extract of G. scortechinii and
fractions were subjected to antimicrobial assay using the
disc diffusion method of Bauer et al. (94). Both Gram-
positive and Gram-negative bacteria (Table 2) were
obtained from the stock cultures of the Department of
Medical Microbiology at the University of Malaya.
The organisms were of the American Typed Culture
Collections (ATCC) and some nosocomial isolates. The
organisms included Bacillus sp., Staphylococcus aureus
ATCC 25923, Staphylococcus aureus ATCC 29213,
Enterococcus faecalis ATCC 24922, Pseudomonas aerugi-
nosa ATCC 27853, Escherichia coli ATCC 25922,
Klebsiella pneumoniae, Shigella sonnei, Shigella flexneri
and a yeast Candida albicans (ATCC 90028). The
organisms selected for testing in this experiment are
commonly responsible for foodborn and nosocomial
bacterial infections (95). Mueller–Hinton agar was pre-
pared according to the manufacturer’s instruction.
It was dispensed into sterile plates in 20ml aliquots.
After gelling and drying, the plates were seeded with
appropriate organisms by streaking evenly in three planes
onto the surface of the medium with cotton swabs.
The inoculum was dried for 5min. Sterile filter paper
disks (6mm diameter) soaked with 50ml of extract
(100mg/ml) were placed onto the agar with flamed
forceps and gently pressed down to ensure contact.
Streptomycin (10mg/disc) and nystatin (100IU) were used
as a positive standard against bacteria and fungi as they
are both inexpensive and broad spectrum antimicrobials.
The plates were incubated at 37 C for 24h. The zones of
inhibition were measured with a ruler. The experiment
was carried out in triplicate. Results obtained for
antibacterial activity of the crude methanol extract of
G. scortechinii and fractions are reported in Table 2.
Methanol, hexane, dichloromethane and water used for
reconstitution of the extracts showed no activity. Analysis
of the data revealed that among the tested fractions,
the dichloromethane fraction exhibited the highest rates
of antibacterial activity. It showed antibacterial activity
against S. aureus ATCC 25923: 23mm, S. aureus ATCC
29213: 27mm, E. faecalis ATCC 24922: 20mm,
Escherichia coli ATCC 25922: 19mm, Bacillus sp.:
20mm, K. pneumoniae: 13mm (Fig. 6), S. sonnei:
28mm, S. flexneri: 13mm, and Proteus sp. 17mm. The
extract inhibited the growth of C. albicans ATCC 90028.
It was inactive against P. aeruginosa ATCC 27853.
This report is the first data available on the antibacte-
rial activity of Goniothalamus species and lends support
the traditional use of Goniothalamus species as post-
partum remedy. An interesting development from these
results would be first to identify the active constituents
and next to study their precise molecular activity against
bacteria. Note that mitochondria in eukaryotic cells take
their origin in pro-bacterial ancestors from which they
inherited NADH:ubiquinone oxidoreductase (96). One
can perhaps envisage a new antibacterial pathway that
would encompass a ‘bacterial apoptosis’. One wonders.
Table 2. Antibacterial activity of extractives from G. scortechinii
HDAMS N
Gram-positive bacteria
Bacillus sp. 13 20 – 20 18
Staphylococcus aureus ATCC 25923 14 27 – 21 16
Staphylococcus aureus ATCC 29213 14 23 – 20 16
Enterococcus faecalis ATCC 24922 – 20 – 14 14
Streptococcus pneumoniae ATCC 49619 – 21 – 13 10
Gram-negative bacteria
Pseudomonas aeruginosa ATCC 27853 – – – – 17
Escherichia coli ATCC 25922 – 19 10 13 20
Klebsiella pneumoniae –1 1 ––2 0
Shigella sonnei 16 28 – 18 20
Shigella flexneri –1 3 7–1 3
Proteus s p . – 1 71 21 02 0
Yeast
Candida albicans ATCC 90028 13 23 – 9 17
Average zone of inhibition (in mm) of triplicate including the diameter
of the filter paper disc (6mm). H¼hexane fraction (5mg/disc)
D¼dichloromethane fraction (5mg/disc) A¼aqueous fraction
(5mg/disc) M¼methanol fraction (5mg/disc) S¼streptomycin
(10mg/disc) N¼Nystatin (100IU).
Figure 6. Antibacterial activity of G. scortechinii against Klebsiella
pneumoniae.
308 Goniothalamus for cancer treatmentConclusion
G. scortechinii was investigated as part of our study on
the medicinal plants of Asia-Pacific (9,10, 97–100) A
critical factor for Goniothalamus’ use as a medicinal
herb is its content of styryl-lactones, which promote
apoptosis in mammalian cells. One might propose the
hypothesis that the abortifacient and/or post-natal
and anti-inflammatory reported traditional uses of
Goniothalamus species might involve styryl-lactones
since apoptosis is known to play a crucial role in
trophoblasts of patients with recurrent spontaneous
abortion of unidentified cause, and in T cells in the
human decidua as defense mechanism against rejection of
fetal allograft by the maternal immune system (101,102).
In addition, goniothalamin induces apoptosis in vascular
smooth muscle cells, the growth of which is required to
allow embryo implantation and the development of the
blood supply for fetal survival and inhibit the cell surface
expression of intercellular adhesion molecule 1 and
vascular cell adhesion molecule 1 on the surface of
murine endothelial cells (103,104)
In regards to the result obtained for antibacterial
activity of the crude methanol extract of G. scortechinii
and fractions, it can be concluded that the dichloro-
methane extract of G. scortechinii is very active against
both Gram-positive and Gram-negative bacteria. and the
results obtained tend to answer positively the question of
Chinnok et al. (105). This work illustrates the fact that
the careful study of the biochemical architecture of
medicinal plants represents a fascinating and fruitful
aspect of pharmaceutical research (106). In regards
G. scortechinii, it will be interesting to know whether
further studies on this plant disclose any molecules
the treatment of nosocomial urinary, respiratory and
wound nosocomial infections (S. aureus, E. coli and
K. pneumoniae) which are developed by hospital patients.
In summary the evidence for the existence of anticancer,
antibacterial and antiviral agents in the genus
Goniothalamus is strong and it seems likely that further
consistent and systematic research on this genus of flower-
ing plants will lead to the discovery of antineoplastic and
antimicrobial agents. If enough botanical, phytochemical
and pharmacological work is dedicated to this discrete
tropical genus of flowering plants, a couple of drugs for the
treatment of tumors and/or bacterial and even viral
infections should be developed in the relatively close future.
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